Building a neuroinfectious disease consensus curriculum

Arun Venkatesan; Felicia C Chow; Allen Aksamit; Russell Bartt; Thomas P Bleck; Cheryl Jay; Daniel M Pastula; Karen L Roos; Jeffrey Rumbaugh; Deanna Saylor; Tracey A Cho

doi:10.1212/WNL.0000000000007872

Back

Building a neuroinfectious disease consensus curriculum

Journal article

Peer reviewed

Building a neuroinfectious disease consensus curriculum

Arun Venkatesan, Felicia C Chow, Allen Aksamit, Russell Bartt, Thomas P Bleck, Cheryl Jay, Daniel M Pastula, Karen L Roos, Jeffrey Rumbaugh, Deanna Saylor, …

Neurology, Vol.93(5), pp.208-216

07/30/2019

DOI: 10.1212/WNL.0000000000007872

PMID: 31253643

View Online

Abstract

To delineate a comprehensive curriculum for fellowship training in neuroinfectious diseases, we conducted a modified Delphi approach to reach consensus among 11 experts in the field. The authors invited a diverse range of experts from the American Academy of Neurology Neuro-Infectious Diseases (AAN Neuro-ID) Section to participate in a consensus process using a modified Delphi technique. A comprehensive list of topics was generated with 101 initial items. Through 3 rounds of voting and discussion, a curriculum with 83 items reached consensus. The modified Delphi technique provides an efficient and rigorous means to reach consensus on topics requiring expert opinion. The AAN Neuro-ID section provided the pool of diverse experts, the infrastructure, and the community through which to accomplish the consensus project successfully. This process could be applied to other subspecialties and sections at the AAN.

Clinical Competence

Central Nervous System Infections

Curriculum

Delphi Technique

Neurology - education

Humans

Details

Title: Subtitle: Building a neuroinfectious disease consensus curriculum
Creators: Arun Venkatesan - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Felicia C Chow - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Allen Aksamit - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Russell Bartt - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Thomas P Bleck - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Cheryl Jay - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Daniel M Pastula - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Karen L Roos - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Jeffrey Rumbaugh - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Deanna Saylor - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City
Tracey A Cho - From the Neuro-Infectious Diseases Section (A.V., F.C.C., A.A., R.B., T.P.B., C.J., D.M.P., K.L.R., J.R., D.S., T.A.C.), American Academy of Neurology, Minneapolis, MN; Johns Hopkins University (A.V., D.S.), Baltimore, MD; University of California (F.C.C., C.J.), San Francisco; Mayo Clinic (A.A.), Rochester, MN; Blue Sky Neurology (R.B.), Englewood, CO; Rush Medical College (T.P.B.), Chicago; University of Colorado and Colorado School of Public Health (D.M.P.), Aurora; Indiana University (K.R.), Indianapolis; Remyelix Neurology & Multiple Sclerosis Institute (J.R.), Tampa, FL; University of Iowa (T.A.C.), Iowa City. tracey-cho@uiowa.edu
Resource Type: Journal article
Publication Details: Neurology, Vol.93(5), pp.208-216
DOI: 10.1212/WNL.0000000000007872
PMID: 31253643
NLM abbreviation: Neurology
ISSN: 0028-3878
eISSN: 1526-632X
Publisher: United States
Language: English
Date published: 07/30/2019
Academic Unit: Neurology; Iowa Neuroscience Institute
Record Identifier: 9984070827402771

Metrics

44 Record Views

4 Times Cited - Web of Science

See more details